Clinical significance of disease‐specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma

Recent sequencing studies demonstrated the MYD88 L265P mutation in more than 70% of primary central nervous system lymphomas (PCNSL), and the clinical significance of this mutation has been proposed as diagnostic and prognostic markers in PCNSL. In contrast, mutational analyses using cell‐free DNAs...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Sci
Asıl Yazarlar: Hattori, Keiichiro, Sakata‐Yanagimoto, Mamiko, Suehara, Yasuhito, Yokoyama, Yasuhisa, Kato, Takayasu, Kurita, Naoki, Nishikii, Hidekazu, Obara, Naoshi, Takano, Shingo, Ishikawa, Eiichi, Matsumura, Akira, Hasegawa, Yuichi, Chiba, Shigeru
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2017
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5765295/
https://ncbi.nlm.nih.gov/pubmed/29151258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13450
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller